Juan Alguacil, MD Huelva University Brussels, 26 June 2012 Limits on Occupational Exposure Limits for Carcinogens 8th Seminar on workers’ protection &

Slides:



Advertisements
Similar presentations
Dosimetry in Risk Assessment and a bit More Mel Andersen McKim Conference QSAR and Aquatic Toxicology & Risk Assessment June 27-29, 2006.
Advertisements

Evaluation of a potential mutagenic MOA based on analysis of the weight of evidence and using the modified Hill criteria Martha M. Moore, Ph.D. Director,
Regulatory Toxicology James Swenberg, D.V.M., Ph.D.
Is depleted uranium a carcinogen? Keith Baverstock PhD Department of Environmental Science University of Kuopio Finland.
Chemical Carcinogens – workplace risk assessment and health surveillance Tiina Santonen Paide.
Carcinogen Classification Criteria Patricia Richter Ph.D., DABT Tobacco Products Scientific Advisory Committee June 8, 2010.
Fundamentals of Industrial Hygiene 6th Edition
Wien.arbeiterkammer.at Revision of the Carcinogens and Mutagens Directive – Why do we need it? Christoph Streissler Arbeiterkammer Wien (Chamber of Labour,
Sensitivity Analysis for Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare Research and Quality (AHRQ)
William H. Farland, Ph.D. Acting Deputy Assistant Administrator for Science Office of Research and Development U.S. ENVIRONMENTAL PROTECTION AGENCY Biomarkers:
NSF/ANSI STANDARD 61 FRAMEWORK FOR RISK ASSESSMENTS For use by Toxicology Sub-committee only Please do not copy or distribute.
Sources of Uncertainty and Current Practice for Addressing Them: Toxicological Perspective David A. Bussard U.S. Environmental Protection Agency The views.
Environmental Health III. Epidemiology Shu-Chi Chang, Ph.D., P.E., P.A. Assistant Professor 1 and Division Chief 2 1 Department of Environmental Engineering.
What Do Toxicologists Do?
Introduction of Cancer Molecular Epidemiology Zuo-Feng Zhang, MD, PhD University of California Los Angeles.
1 Issues in Harmonizing Methods for Risk Assessment Kenny S. Crump Louisiana Tech University
Risk Assessment II Dec 9, Is there a “safe” dose ? For effects other than cancer:
Environmental Risk Assessment of Pharmaceutical Mixtures: - empirical knowledge, gaps and regulatory options Thomas Backhaus University of Gothenburg
The EU Scientific Committee on Occupational Exposure Limits (SCOEL) Presentation by Professor Len Levy, Cranfield University (Vice-Chair of SCOEL)
Criteria for Screens— Review of the EDSTAC Recommendations Presentation to the EDMVS July 23, 2002.
ILSI Risk Science Institute Acrylamide Toxicity: Research to Address Key Data Gaps Presented by Dr. Stephen S. Olin ILSI Risk Science Institute.
TCEQ/NUATRC Air Toxics Workshop: Session V – Human Health Effects Nathan Pechacek, M.S. Toxicology Section Texas Commission on Environmental Quality
EPA’s cancer risk assessment guidelines: General overview Jim Cogliano, Ph.D. United States Environmental Protection Agency* Office of Research and Development.
Lecture #3 Hazards and their effects. Epidemiology = The study of the distribution and causes of disease and injuries in human populations. – Epidemiologists.
BIOLOGIC MARKERS IN OCCUPATIONAL AND ENVIRONMENTAL MEDICINE By: Dr Chavoshi.
Food Advisory Committee Meeting December 16 and 17, 2014 Questions to the Committee Suzanne C. Fitzpatrick, PhD, DABT Senior Advisory for Toxicology Center.
Health and Safety Executive UK Approach to Risk Assessment of Genotoxic Carcinogens in the Occupational Setting Dr Susy Brescia Chemicals Regulation Directorate.
Committee on Carcinogenicity (COC) Approach to Risk Assessment of Genotoxic Carcinogens David H. Phillips* COC Chairman Descriptive vs. Quantitative.
Photo image area measures 2” H x 6.93” W and can be masked by a collage strip of one, two or three images. The photo image area is located 3.19” from left.
28/05/12 Questions (Rispondete alle domande che seguono usando il colore rosso per il testo) Tossicologia - Rubbiani Maristella.
Dr. Manfred Wentz Director, Hohenstein Institutes (USA) Head, Oeko-Tex Certification Body (USA) AAFA – Environmental Committee Meeting November 10, 2008.
Web of Causation; Exposure and Disease Outcomes Thomas Songer, PhD Basic Epidemiology South Asian Cardiovascular Research Methodology Workshop.
TRAINING FOR THE HEALTH SECTOR
Study Designs Afshin Ostovar Bushehr University of Medical Sciences Bushehr, /4/20151.
Exploratory IND Studies
Chapter 15 Environmental Health, Pollution and Toxicology.
Environmental Hazards & Human Health
Risk Assessment Nov 7, 2008 Timbrell 3 rd Edn pp Casarett & Doull 7 th Edn Chapter 7 (pp )
Dr. Antone Brooks Washington State University Tri-cities Richland, Washington Linear-No-Threshold Hypothesis- Scientific Evidence?
Biomarkers Biomarkers - markers in biological systems with a sufficently long half-life which allow location where in the biological system change occur.
MAIN TOXICITY TESTING. TESTING STRATEGIES A number of different types of data are used in order to establish the safety of chemical substances for use.
Prof. Dr. Wolfgang Dekant Department of Toxicology University of Würzburg Germany Risk, Hazard, and Innovation.
SCOEL and Carcinogens Group A: Non-threshold genotoxic carcinogens; for risk low-dose assessment the linear non-threshold (LNT) model appears appropriate.
Chapter 2 Using Science to Address Environmental Problems.
Reading Health Research Critically The first four guides for reading a clinical journal apply to any article, consider: the title the author the summary.
Chapter 15.3 Risk Assessment 2002 WHO report: “Focusing on risks to health is the key to preventing disease and injury.” risk assessment—process of evaluating.
RISK DUE TO AIR POLLUTANTS
‘DOSE’-‘OUTCOME’ IN GENERAL Relationship between a measured outcome associated with a measured dose –‘outcome’ = level of biological response or prevalence.
Furan-Induced Cytotoxicity, Cell Proliferation, and Tumorgenicity in Mouse Liver Dr. Glenda Moser.
The Future of Chemical Toxicity Testing in the U.S.
Pediatric Subcommittee of the AIDAC October 29-30, Topical Immunosuppressants (Calcineurin Inhibitors) - Animal Toxicology October 30, 2003 Barbara.
Perspective on the current state-of-knowledge of mode of action as it relates to the dose response assessment of cancer and noncancer toxicity Jennifer.
QSAR in CANCER ASSESSMENT PURPOSE and AGENDA Gilman Veith Duluth MN May 19-21, 2010.
Responsible Officer, Volume 112 Monographs Programme
Key Concepts on Health Risk Assessment of Chemical Mixtures.
Acute Toxicity Studies Single dose - rat, mouse (5/sex/dose), dog, monkey (1/sex/dose) 14 day observation In-life observations (body wt., food consumption,
1 Risk Assessment for Air Toxics: The 4 Basic Steps NESCAUM Health Effects Workshop Bordentown, NJ July 30, 2008.
CHAPTER 5 Occupational Exposure Limits and Assessment of Workplace Chemical Risks.
FIFRA SAP Meeting February 2, 2010
Evaluating Cumulative Impacts: The Value of Epidemiology
Biologic Monitoring A. H. Mehrparvar, MD
Risk Assessment Dec 4 -6, 2006.
Introduction to Environmental Engineering and Science (3rd ed.)
Fundamentals of Industrial Hygiene 6th Edition
OAK CREEK Toxicology & Risk Assessment Consulting
Risk Assessment Dec 7, 2009 Timbrell 3rd Edn pp 16-21
Using Mode of Action to Reduce Uncertainty in Risk Estimates
Evaluating Cumulative Impacts: The Value of Epidemiology
Objective 2 Biomedical Research Methods
Presentation transcript:

Juan Alguacil, MD Huelva University Brussels, 26 June 2012 Limits on Occupational Exposure Limits for Carcinogens 8th Seminar on workers’ protection & chemicals Threshold vs. Non Threshold Carcinogens

OUTLINE Cancer is a chronic disease where cumulated long term exposure is relevant, and 8-hour thresholds do not account for chronic exposure Update of the documental basis can be improved Most thresholds are not based on studies in humans (epidemiological or toxicological) Thresholds, concomitant exposures and mixtures Chemicals with multiple mechanisms of action Validity of inferences for low-dose effects and accuracy of NOAELs

OUTLINE Cancer is a chronic disease where cumulated long term exposure is relevant, and 8-hour thresholds do not account for chronic exposure Update of the documental basis can be improved Most thresholds are not based on studies in humans (epidemiological or toxicological) Thresholds, concomitant exposures and mixtures Chemicals with multiple mechanisms of action Validity of inferences for low-dose effects and accuracy of NOAELs

Dr. Juan Alguacil Ojeda Huelva University Comparison of Toenails and Urine as Matrices for Bio-Monitoring of Metal Levels in Exposed Workers

STUDY POPULATION TABLE 1: Main Characteristics

RESULTS

CONCLUSION Multielemental analysis of toenail samples properly captures occupational exposure to metals, and might be useful when long term bio- monitoring be of interest

CUMULATIVE EXPOSURE 8-hours based exposure limits account for the acute effect of a dose that takes into account a correction factor for a life-long term occupational exposure, but do not account for the chronic (continuous) effect of the cumulative exposure Noise is a good example (though not carcinogenic) Need for studies based in humans (e.g. cohorts of workers, environmentally exposed populations) to assess the risk of cumulative exposure Known carcinogenic agents increasing the risk at chronic environmental exposure are candidates to follow

OUTLINE Cancer is a chronic disease where cumulated long term exposure is relevant, and 8-hour thresholds do not account for chronic exposure Update of the documental basis can be improved Most thresholds are not based on studies in humans (epidemiological or toxicological) Thresholds, concomitant exposures and mixtures Chemicals with multiple mechanisms of action Validity of inferences for low doses effects and accuracy of NOAELs

Update for the documental basis can be improved No need to re-invent the wheel but … Need to update scientific toxicological information that gives support to TLVs when necessary Take into account new assays/methods and not only the classical ones Scarce epidemiological and toxicological studies in humans

OUTLINE Cancer is a chronic disease where cumulated long term exposure is relevant, and 8-hour thresholds do not account for chronic exposure Update of the documental basis can be improved Most thresholds are not based on studies in humans (epidemiological or toxicological) Thresholds, concomitant exposures and mixtures Chemicals with multiple mechanisms of action Validity of inferences for low doses effects and accuracy of NOAELs

Thresholds not based on studies in humans The most comprehensive analysis of genotoxicity and carcinogenesis data showed that the genotoxicity testing battery is highly sensitive for detection of carcinogens, detecting 93% of carcinogens However, the testing paradigm features low specificity (Kirkland et al.,2005, 2006) 50% of the noncarcinogens among marketed pharmaceuticals had some positive genotoxicity findings (Snyder and Green, 2001) The discrepancy is due to limitations of genotoxicity endpoints and assays, such as insufficiency of certain in vitro assays to model the in vivo target organ situation and the complexity of carcinogenic mechanisms

Thresholds not based on studies in humans In case of carcinogenicity studies, the analysis of several databases showed that 50% of compounds tested positive in at least one species or sex (Hoffmann and Hartung, 2006; MacDonald, 2004) This high incidence and other research questioned the human relevance for of tumors induced in rodents (Knight et al., 2006;Ward, 2007) Arsenic would be an example of the lack of sensitivity of animal models to identify human carcinogens

Thresholds not based on studies in humans Scientifically, it may be more appropriate to identify key mechanisms involved in human carcinogenesis as a means to identify the agents that can play a role in advancing these mechanisms—rather than starting with an animal tumor and evaluating whether each event is similar or different in humans

OUTLINE Cancer is a chronic disease where cumulated long term exposure is relevant, and 8-hour thresholds do not account for chronic exposure Update of the documental basis can be improved Most thresholds are not based on studies in humans (epidemiological or toxicological) Thresholds, concomitant exposures and mixtures Chemicals with multiple mechanisms of action Validity of inferences for low doses effects and accuracy of NOAELs

Some Common Multiple Exposures

Thresholds, concomitant exposures and mixtures Several agents can affect the same organ Within a mixture, usually, the risk assessment is based on the agent more toxic in the mixture (Kortekamp A. 2008)  No problems when there is only one toxic agent in the mixture  or when the total toxicity of the mixture is higher than the toxicity of such agent

Thresholds, concomitant exposures and mixtures ACGIH, and Directive (98/24/EC) recommend assuming additive effects when substances affect the same organ, unless there is evidence for non-additive effects The effect of concomitant exposures can be additive… or not...  Arsenic and cadmium potentiate their effects on kidney toxicity  The effect can be antagonistic (e.g. for some xenoestrogens (Rajapakse et al 2004)) Some xenoestrogens can interact at levels below their NOAEL (Silva et al 2002)

Concomitant exposures and mixtures “Mixie” Database developed by the Canadian Institute Robert-Sauvé   Data for about 700 agents  Identifies when two agents can affect the same organ and provides information on whether there are studies on the interaction between both agents

OUTLINE Cancer is a chronic disease where cumulated long term exposure is relevant, and 8-hour thresholds do not account for chronic exposure Update of the documental basis can be improved Most thresholds are not based on studies in humans (epidemiological or toxicological) Thresholds, concomitant exposures and mixtures Chemicals with multiple mechanisms of action Validity of inferences for low doses effects and accuracy of NOAELs

Multiple mechanisms of action

Multiple mechanisms There are no routine screening tests for mechanisms other than genotoxicity, including the epigenetic effects that can also play a critical role in induction and progression of human cancer Available genotoxicity tests do not readily accommodate the concept that a single chemical may have multiple impacts on the carcinogenic process

Multiple mechanisms The analysis of 8 selected Group I carcinogens considered whether chemical carcinogens may act through multiple mechanisms and found that simple dichotomous characterization regarding whether a chemical is ‘‘genotoxic’’ or ‘‘non- genotoxic,’’ though often part of risk assessment approaches, is not particularly informative

Multiple mechanisms IARC recently modified its guidelines to allow an agent to be classified as possibly carcinogenic to humans (Group 2B) ‘‘solely on the basis of strong evidence from mechanistic and other relevant data’’ (Before this change, a classification in Group 2B required at least limited evidence of carcinogenicity in experimental animals)

OUTLINE Cancer is a chronic disease where cumulated long term exposure is relevant, and 8-hour thresholds do not account for chronic exposure Update of the documental basis can be improved Most thresholds are not based on studies in humans (epidemiological or toxicological) Thresholds, concomitant exposures and mixtures Chemicals with multiple mechanisms of action Validity of inferences for low-dose effects and accuracy of NOAELs

Dose Response and NOAEL Available mechanistic data typically come from high dose experiments that have rarely been conducted in the context of or under conditions that are comparable to animal bioassays or epidemiologic studies in which increased cancer risk was observed Thus, reaching conclusions about the mode of action of a chemical at low doses is almost always difficult and controversial

Dose Response and NOAEL A good modeling of the dose-response relationship can provide useful information on the mechanism/s of action The dose-response relationship for genotoxic carcinogenic agents is based on animal data, and the inference to humans implies some limitations (assumptions on toxicokinetics, toxicodynamics, metabolism, mechanism of actions, influence of non genotoxic mechanism, and susceptible populations) The NOAEL approach does not provide empirical information on biological processes below the NOAEL, increasing uncertainty on the magnitude of variability below such level Will DNELs susbtitute NOAELs?

Dose Response and NOAEL Lucier et al. stated that the dose–response curve would in fact be linear in the low-dose region because the ‘‘occupancy of one receptor would produce a response, although it is unlikely that this response could be detected’’ experimentally Human variability and background exposure tend to broaden and increase the linearity of the dose–response curve “Each modulating factor divides the population up into subpopulations of different susceptibility so that nonlinearities that could be present in a homogeneous population are flattened out. A linear extrapolation of a human cancer risk to low dose might therefore be appropriate under certain conditions even if the dose–response curve in animals has a strongly sigmoidal (non-linear) shape” (Lutz 1999)

Dose Response and NOAEL The concept that mechanisms inform the shape of the dose– response curve at low doses has been challenged by several experimental studies including the recent demonstrations that the dose–response curves for assays for gene mutations show a non-linear or apparent threshold response for some (MMS and EMS) but not all (MNU or ENU) mutagens (Doak et al 2007) On the other hand, no threshold has been demonstrated for diverse effects including non-genotoxic effects, such as receptor binding and clastogenesis (chromosome breakage leading to micronucleus formation) from mitomycin C and diepoxybutane (Grawe et al 1998) DNA adduct formation following exposure to benzene and other chemicals in rodents also lacks an apparent threshold